Skip to content
Screener

Clover Health Investments CLOV Insurance segment — Premium deficiency reserve benefit

Similar metrics at other companies

CVS Health logo
CVSPremium deficiency reserve
$15M-98.3%
Privia Health Group, Inc. logo
PRVAPremium deficiency reserve release
$500.48M+23.3%
Centene logo
CNCMedicare — Plus: Premium deficiency reserve
$0-100%
Employers Holdings logo
EIGPremium Deficiency
$0
CVS Health logo
CVSMedicaid Product Line — Premium deficiency reserve
$15M
Citizens logo
CIADomestic Insurance Segment — Future policy benefit reserve
$257.09M+3.0%

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.45B+113%
P/S1.1×+0.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept clov:PremiumDeficiencyTestingBenefitLongDurationContractAmount.

The source filing: Clover Health Investments’s 10-K, filed February 27, 2026.

Filed
Feb 27, 2026, 8:08 AM EST
Fiscal year
FY2025
Accession
0001801170-26-000057
Line itemYear ended December 31, 2025Year ended December 31, 20242023
Salaries and benefits225,475232,454257,157
General and administrative expenses214,270176,480183,089
Impairment of goodwill and other intangible assets15,945
Premium deficiency reserve benefit(7,239)
Depreciation and amortization1,6861,3312,509
Restructuring costs2889,821
Total operating expenses2,009,8371,416,8801,465,872
Loss from continuing operations(85,529)(45,749)(205,329)

Item 8. Consolidated Financial Statements and Supplementary Data

FAQ

What is Clover Health Investments's insurance segment — premium deficiency reserve benefit?
Clover Health Investments (CLOV) reported insurance segment — premium deficiency reserve benefit of $0 in Q4 2025.
What is the long-term trend for Clover Health Investments's insurance segment — premium deficiency reserve benefit?
Over 2 years (2023 to 2025), Clover Health Investments's insurance segment — premium deficiency reserve benefit has grown at a -100.0% compound annual growth rate (CAGR), from $7.24M to $0.
What does insurance segment — premium deficiency reserve benefit mean?
This represents the reversal or reduction of reserves previously established for insurance contracts where expected future claims and expenses exceed anticipated premiums. A benefit indicates that the underlying profitability of the insurance portfolio has improved, reducing the need for loss-recognition reserves. It serves as a key indicator of actuarial performance and the adequacy of premium pricing within the insurance segment.

Ask your AI about Clover Health Investments's insurance segment — premium deficiency reserve benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude